Geode Capital Management LLC lessened its stake in National HealthCare Co. (NYSE:NHC - Free Report) by 1.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 288,662 shares of the company's stock after selling 3,824 shares during the quarter. Geode Capital Management LLC owned about 1.87% of National HealthCare worth $31,056,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of NHC. Barclays PLC raised its position in shares of National HealthCare by 345.6% in the 3rd quarter. Barclays PLC now owns 21,063 shares of the company's stock valued at $2,649,000 after buying an additional 16,336 shares in the last quarter. American Century Companies Inc. increased its stake in National HealthCare by 10.6% in the fourth quarter. American Century Companies Inc. now owns 32,141 shares of the company's stock valued at $3,457,000 after acquiring an additional 3,084 shares during the last quarter. Principal Financial Group Inc. raised its position in National HealthCare by 3.5% during the fourth quarter. Principal Financial Group Inc. now owns 63,739 shares of the company's stock valued at $6,856,000 after purchasing an additional 2,140 shares in the last quarter. Jane Street Group LLC lifted its stake in National HealthCare by 213.3% during the third quarter. Jane Street Group LLC now owns 28,887 shares of the company's stock worth $3,633,000 after purchasing an additional 19,667 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of National HealthCare by 6.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 43,073 shares of the company's stock valued at $5,417,000 after purchasing an additional 2,419 shares in the last quarter. Institutional investors own 56.44% of the company's stock.
Wall Street Analyst Weigh In
Separately, StockNews.com cut National HealthCare from a "strong-buy" rating to a "buy" rating in a report on Monday, March 3rd.
Get Our Latest Stock Report on National HealthCare
National HealthCare Stock Down 1.3 %
Shares of NYSE NHC opened at $91.57 on Thursday. The stock has a 50-day moving average price of $94.14 and a two-hundred day moving average price of $108.00. National HealthCare Co. has a 12 month low of $87.03 and a 12 month high of $138.49. The company has a current ratio of 1.80, a quick ratio of 1.77 and a debt-to-equity ratio of 0.14. The company has a market cap of $1.42 billion, a price-to-earnings ratio of 11.47 and a beta of 0.42.
National HealthCare Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.61 dividend. This represents a $2.44 annualized dividend and a yield of 2.66%. The ex-dividend date of this dividend is Friday, March 28th. National HealthCare's payout ratio is 37.31%.
National HealthCare Company Profile
(
Free Report)
National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider National HealthCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National HealthCare wasn't on the list.
While National HealthCare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.